Evidence map›Paper›PMID 36321446›Full record

ArticleCirculation research2022

The

Elisavet Karamanavi, David G McVey, Sander W van der Laan, Paulina J Stanczyk, Gavin E Morris, Yifan Wang, Wei Yang, Kenneth Chan, Robin N Poston, Jun Luo and 13 more

Open access · hybridAbstract read
In one paragraph

Article in Circulation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 6 pooled it
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 6 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Identification ofDepression and anxiety · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 6 countries.

Elisavet KaramanaviDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
David G McVeyDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).ORCID 0000-0002-6402-2546
Sander W van der LaanCentral Diagnostic Laboratory, University of Utrecht, The Netherlands (S.W.v.d.L., G.P.).ORCID 0000-0001-6888-1404
Paulina J StanczykDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
Gavin E MorrisDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
Yifan WangCardiovascular Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore (Y.W., H.Y., S.Y.).ORCID 0000-0001-5525-3169
Wei YangShantou University Medical College, China (W.Y., J.C., S.Y.).
Kenneth ChanWilliam Harvey Research Institute, Queen Mary University of London, United Kingdom (K.C., R.N.P., J.L., X.Z., Q.X.).ORCID 0000-0002-5571-7549
Robin N PostonWilliam Harvey Research Institute, Queen Mary University of London, United Kingdom (K.C., R.N.P., J.L., X.Z., Q.X.).
Jun LuoWilliam Harvey Research Institute, Queen Mary University of London, United Kingdom (K.C., R.N.P., J.L., X.Z., Q.X.).
Xinmiao ZhouWilliam Harvey Research Institute, Queen Mary University of London, United Kingdom (K.C., R.N.P., J.L., X.Z., Q.X.).ORCID 0000-0003-2235-0338
Peng GongDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
Peter D JonesDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
Junjun CaoShantou University Medical College, China (W.Y., J.C., S.Y.).
Renata B KostogrysDepartment of Human Nutrition, University of Agriculture in Kraków, Poland (R.B.K.).ORCID 0000-0002-7972-7522
Tom R WebbDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).ORCID 0000-0001-5998-8226
Gerard PasterkampCentral Diagnostic Laboratory, University of Utrecht, The Netherlands (S.W.v.d.L., G.P.).ORCID 0000-0001-5345-1022
Haojie YuCardiovascular Disease Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore (Y.W., H.Y., S.Y.).ORCID 0000-0002-0559-0252
Qingzhong XiaoWilliam Harvey Research Institute, Queen Mary University of London, United Kingdom (K.C., R.N.P., J.L., X.Z., Q.X.).ORCID 0000-0001-9101-0498
Peter A GreerDepartment of Pathology and Molecular Medicine, Queen's University, Kingston, Canada (P.A.G.).
Emma J StringerDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).
Nilesh J SamaniDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).ORCID 0000-0002-3286-8133
Shu YeDepartment of Cardiovascular Sciences, University of Leicester, and National Institute for Health Research Leicester Biomedical Research Centre, Leicester, United Kingdom (E.K., D.G.M., P.J.S., G.E.M., P.G., P.D.J., T.R.W., E.J.S., N.J.S., S.Y.).ORCID 0000-0002-4126-4278
NIHR Leicester Biomedical Research Centre · GBQueen Mary University of London · GBNational University of Singapore · SGShantou University · CNUtrecht University · NLNIHR Leicester Cardiovascular Biomedical Research Unit · GBQueen's University · CAUniversity of Agriculture in Krakow · PL

Funding

British Heart Foundation PG/13/45/30326British Heart Foundation PG/15/86/31723British Heart Foundation PG/16/1/31892British Heart Foundation PG/16/9/3199British Heart Foundation PG/16/9/31995British Heart Foundation PG/18/73/34059British Heart Foundation PG/20/10458British Heart Foundation RG/16/13/32609British Heart Foundation RG/19/9/34655British Heart Foundation SP/19/2/344612
6 · The paper itself

Abstract

backgroundGenome-wide association studies have discovered a link between genetic variants on human chromosome 15q26.1 and increased coronary artery disease (CAD) susceptibility; however, the underlying pathobiological mechanism is unclear. This genetic locus contains the METHODS AND

resultsAnalyses of isogenic monocytic cell lines generated by CRISPR (clustered regularly interspaced short palindromic repeats)-mediated genome editing showed that monocytes with an engineered 15q26.1 CAD risk genotype had reduced FES expression. Small-interfering-RNA-mediated knockdown of FES promoted migration of monocytes and vascular smooth muscle cells. A phosphoproteomics analysis showed that FES knockdown altered phosphorylation of a number of proteins known to regulate cell migration. Single-cell RNA-sequencing revealed that in human atherosclerotic plaques, cells that expressed

conclusionsWe provide substantial evidence that the CAD risk variants at the 15q26.1 locus reduce FES expression in monocytes and that FES depletion results in larger atherosclerotic plaques with more monocytes/macrophages and smooth muscle cells. This study is the first demonstration that FES plays a protective role against atherosclerosis and suggests that enhancing FES activity could be a potentially novel therapeutic approach for CAD intervention.

Indexed as

AtherosclerosisCoronary Artery DiseasePlaque, AtheroscleroticProto-Oncogene Proteins c-fesAnimalsArteriesGenome-Wide Association StudyHumansMiceMyocytes, Smooth MuscleFES protein, humanFes protein, mouseProto-Oncogene Proteins c-fesatherosclerosiscoronary artery diseaseFESgeneticsmonocytes

Identifiers

PMID36321446
PMCPMC9770135
OpenAlexW4307976048

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.